SCM

Soleus Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 18.23%
This Quarter Est. Return
1 Year Est. Return
+18.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$173M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
102
New
Increased
Reduced
Closed

Top Buys

1
+$66.1M
2
+$34.8M
3
+$29.9M
4
ELV icon
Elevance Health
ELV
+$27.2M
5
UNH icon
UnitedHealth
UNH
+$26.9M

Top Sells

1
+$21.7M
2
+$20.3M
3
+$18.7M
4
MRUS icon
Merus
MRUS
+$18.2M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18M

Sector Composition

1 Healthcare 99.87%
2 Consumer Staples 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKIN icon
76
The Beauty Health Co
SKIN
$170M
$1.91M 0.13%
+1,000,000
MREO
77
Mereo BioPharma
MREO
$339M
$1.63M 0.11%
599,711
-87,242
YMAB
78
DELISTED
Y-mAbs Therapeutics
YMAB
$1.58M 0.1%
349,982
TECX
79
Tectonic Therapeutic
TECX
$355M
$1.53M 0.1%
76,841
MYO icon
80
Myomo
MYO
$42.3M
$1.52M 0.1%
704,275
CALC icon
81
CalciMedica
CALC
$43.7M
$1.25M 0.08%
783,904
EWTX icon
82
Edgewise Therapeutics
EWTX
$1.63B
$1M 0.07%
76,493
+4,193
KIDS icon
83
OrthoPediatrics
KIDS
$449M
$967K 0.06%
45,000
ABVX
84
Abivax
ABVX
$7.13B
$956K 0.06%
125,000
CBLL
85
CeriBell Inc
CBLL
$491M
$937K 0.06%
+50,000
SLNO icon
86
Soleno Therapeutics
SLNO
$3.57B
$838K 0.06%
10,000
-140,000
SEPN
87
Septerna Inc
SEPN
$950M
$798K 0.05%
75,456
-675,897
BCYC
88
Bicycle Therapeutics
BCYC
$575M
$695K 0.05%
+100,000
ADVM icon
89
Adverum Biotechnologies
ADVM
$93.8M
$618K 0.04%
287,246
RVMD icon
90
Revolution Medicines
RVMD
$10B
$368K 0.02%
10,000
-74,784
DCTH icon
91
Delcath Systems
DCTH
$398M
$340K 0.02%
25,000
-207,722
IOBT icon
92
IO Biotech
IOBT
$67.2M
$268K 0.02%
192,670
AXSM icon
93
Axsome Therapeutics
AXSM
$6.56B
$209K 0.01%
2,000
-15,000
ADPT icon
94
Adaptive Biotechnologies
ADPT
$2.64B
$117K 0.01%
10,000
APGE icon
95
Apogee Therapeutics
APGE
$3.78B
– –
-16,000
HOLX icon
96
Hologic
HOLX
$16.5B
– –
-302,000
LIVN icon
97
LivaNova
LIVN
$2.99B
– –
-117,040
PTGX icon
98
Protagonist Therapeutics
PTGX
$4.67B
– –
-169,000
SNY icon
99
Sanofi
SNY
$121B
– –
-226,218
SRPT icon
100
Sarepta Therapeutics
SRPT
$2.44B
– –
-58,000
1 2 3
4
5